Long Noncoding RNA LINC02249 Is a Prognostic Biomarker and Correlates with Immunosuppressive Microenvironment in Skin Cutaneous Melanoma

Table 1

Association of LINC02249 expression levels with clinical factors in SKCM patients.

Characteristics	Low expression of LINC02249	High expression of LINC02249
n	235	236
Age, n (%)			0.200
≤60	132 (28.5%)	120 (25.9%)
>60	97 (21%)	114 (24.6%)
Gender, n (%)			0.063
Female	79 (16.8%)	100 (21.2%)
Male	156 (33.1%)	136 (28.9%)
Pathologic stage, n (%)			0.061
Stage I	46 (11.2%)	31 (7.5%)
Stage II	57 (13.8%)	83 (20.1%)
Stage III	84 (20.4%)	87 (21.1%)
Stage IV	11 (2.7%)	13 (3.2%)
Radiation therapy, n (%)			0.120
No	183 (39.4%)	200 (43.1%)
Yes	47 (10.1%)	34 (7.3%)
Age, median (IQR)	57 (47, 68)	60 (48, 73)	0.040